Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

AZN

Astrazeneca (AZN)

Astrazeneca Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AZN
DateHeureSourceTitreSymboleSociété
02/05/202411h04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202408h00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202416h00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202410h13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202408h05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202414h00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202410h18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202408h00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202411h32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
16/04/202412h38Alliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
16/04/202409h39Alliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
11/04/202418h42Alliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
11/04/202418h30RNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
11/04/202409h56Alliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
11/04/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
08/04/202409h36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
08/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
08/04/202407h53Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approvalLSE:AZNAstrazeneca Plc
05/04/202410h42Alliance NewsAlliance NewsAstraZeneca makes "breakthrough" in treating small cell lung cancerLSE:AZNAstrazeneca Plc
05/04/202408h00RNS Regulatory NewsAstraZeneca PLC Imfinzi improved OS & PFS in limited-stage SCLCLSE:AZNAstrazeneca Plc
03/04/202412h02Alliance NewsAlliance NewsCORRECT: AstraZeneca, Daiichi make US progress with licence approvalsLSE:AZNAstrazeneca Plc
02/04/202411h25Alliance NewsAlliance NewsAstraZeneca and Daiichi make US progress with latest licence approvalsLSE:AZNAstrazeneca Plc
02/04/202408h05RNS Regulatory NewsAstraZeneca PLC Voydeya approved in USLSE:AZNAstrazeneca Plc
02/04/202408h00RNS Regulatory NewsAstraZeneca PLC FDA accepts Dato-DXd BLA for breast cancerLSE:AZNAstrazeneca Plc
27/03/202410h19Alliance NewsAlliance NewsAstraZeneca treatments become "first and only" to be approved in JapanLSE:AZNAstrazeneca Plc
25/03/202409h40Alliance NewsAlliance NewsTOP NEWS: AstraZeneca wins US approval for rare nervous system diseaseLSE:AZNAstrazeneca Plc
25/03/202408h00RNS Regulatory NewsAstraZeneca PLC Ultomiris approved in the US for NMOSDLSE:AZNAstrazeneca Plc
21/03/202417h43Alliance NewsAlliance NewsAstraZeneca's Tagrisso successful in treating lung cancerLSE:AZNAstrazeneca Plc
19/03/202409h56Alliance NewsAlliance NewsTOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billionLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN